AN OVERVIEW OF THE RHEUMATOLOGY OUTPATIENT CLINIC VISITS IN THE FIRST 16 MONTHS OF THE COVID-19 PANDEMIC: SINGLE-CENTRE EXPERIENCE

Hüseyin Kaplan; Gizem Cengiz; Senem Şaş; Emre Şenköy

Makale detayları

AN OVERVIEW OF THE RHEUMATOLOGY OUTPATIENT CLINIC VISITS IN THE FIRST 16 MONTHS OF THE COVID-19 PANDEMIC: SINGLE-CENTRE EXPERIENCE

Yazarlar:

Hüseyin Kaplan | Gizem Cengiz | Senem Şaş | Emre Şenköy

Yayıncı:

Erciyes University

Ana Başlıklar:

İç Hastalıkları

Dergi:

Sağlık Bilimleri Dergisi Vol.32 Issue 1, pp.106-112

Belge Tipi:

Makale

Yayın Tarihi:

3/2023

Belge Dili:

İngilizce

Document ID (Org No.):

2001286286

pISSN:

1018-3655

Anahtar kelimeler:

Özet:

 The aim of this study is to present a general picture of patients who applied to the rheumatology outpatient clinic in the first 16 months of the COVID-19pandemic. Patients who applied to the rheumatology outpatient clinic between March 2020 and August 2021 were included in the study. Patients clinical and demographic characteristics, the received drug treatments at their last admissions, and the outpatient clinic visits of patients within the specified 16-month period were evaluated retrospectively. A total of 869 patients were included, and their mean age was 48.51  12.84 years; of these, 658 75.71 were female and 211 24.29 were male. The most common disease diagnosis was rheumatoid arthritis 29.57. The average number of hospital visits in 2021 was significantly higher than in 2020. Also, patients who received both biological disease-modifying antirheumatic drugs bDMARDs and conventional synthetic disease-modifying antirheumatic drugs csDMARDsimmunosuppressives had a significantly higher number of admissions than those who did not for all, p0.05. The patients were divided into two groups based on their age as over and under 65 years of age, the number of outpatient clinic admissions was similar between the groups p0.620.We determined that the year of admission, gender, and the drugs used had significant effects on the number of applications during this period. These and other effects of the pandemic on rheumatic diseases should be demonstrated in multicenter prospective studies.

 The aim of this study is to present a general picture of patients who applied to the rheumatology outpatient clinic in the first 16 months of the COVID-19pandemic. Patients who applied to the rheumatology outpatient clinic between March 2020 and August 2021 were included in the study. Patients clinical and demographic characteristics, the received drug treatments at their last admissions, and the outpatient clinic visits of patients within the specified 16-month period were evaluated retrospectively. A total of 869 patients were included, and their mean age was 48.51  12.84 years; of these, 658 75.71 were female and 211 24.29 were male. The most common disease diagnosis was rheumatoid arthritis 29.57. The average number of hospital visits in 2021 was significantly higher than in 2020. Also, patients who received both biological disease-modifying antirheumatic drugs bDMARDs and conventional synthetic disease-modifying antirheumatic drugs csDMARDsimmunosuppressives had a significantly higher number of admissions than those who did not for all, p0.05. The patients were divided into two groups based on their age as over and under 65 years of age, the number of outpatient clinic admissions was similar between the groups p0.620.We determined that the year of admission, gender, and the drugs used had significant effects on the number of applications during this period. These and other effects of the pandemic on rheumatic diseases should be demonstrated in multicenter prospective studies.

 The aim of this study is to present a general picture of patients who applied to the rheumatology outpatient clinic in the first 16 months of the COVID-19pandemic. Patients who applied to the rheumatology outpatient clinic between March 2020 and August 2021 were included in the study. Patients clinical and demographic characteristics, the received drug treatments at their last admissions, and the outpatient clinic visits of patients within the specified 16-month period were evaluated retrospectively. A total of 869 patients were included, and their mean age was 48.51  12.84 years; of these, 658 75.71 were female and 211 24.29 were male. The most common disease diagnosis was rheumatoid arthritis 29.57. The average number of hospital visits in 2021 was significantly higher than in 2020. Also, patients who received both biological disease-modifying antirheumatic drugs bDMARDs and conventional synthetic disease-modifying antirheumatic drugs csDMARDsimmunosuppressives had a significantly higher number of admissions than those who did not for all, p0.05. The patients were divided into two groups based on their age as over and under 65 years of age, the number of outpatient clinic admissions was similar between the groups p0.620.We determined that the year of admission, gender, and the drugs used had significant effects on the number of applications during this period. These and other effects of the pandemic on rheumatic diseases should be demonstrated in multicenter prospective studies.

 Bu çalışmanın amacı, COVID-19 pandemisinin ilk 16 ayında romatoloji polikliniğine başvuran hastaların genel bir resmini sunmaktır. Mart 2020-Ağustos 2021 tarihleri arasında romatoloji polikliniğine başvuran hastalar çalışmaya dahil edildi. Hastaların klinik ve demografik özellikleri, son başvurularında kullandıkları ilaç tedavileri ve belirlenen 16 aylık süre içerisinde poliklinik ziyaretleri retrospektif olarak değerlendirildi. Toplam 869 hasta dahil edildi ve hastaların ortalama yaşları 48.51  12.84, 658i 75.71 kadın, 211i 24.29 erkekti. En sık görülen hastalık tanısı romatoid artrit 29.57 idi.2021deki ortalama hastane ziyareti sayısı 2020den istatistiksel anlamlı olarak daha yüksekti. Ayrıca, hem biyolojik hastalık modifiye edici antiromatizmal ilaçlar bDMARDlar hem de konvansiyonel sentetik hastalık modifiye edici antiromatizmal ilaçlar csDMARDlarimmünosupresifler alan hastalar almayanlara göre daha yüksek başvuru sayısına sahipti tümü için, p0.05. Hastalar yaşlarına göre 65 yaş üstü ve altı olmak üzere iki gruba ayrıldığında poliklinik başvuru sayıları gruplar arasında benzerdi p0.620.Bu dönemde başvuru sayıları üzerine başvuru yılı, cinsiyet ve kullanılan ilaçların önemli etkileri olduğunu belirledik. Pandeminin romatizmal hastalıklar üzerindeki bu ve diğer etkileri çok merkezli prospektif çalışmalarla gösterilmelidir.

Makale detayları

AN OVERVIEW OF THE RHEUMATOLOGY OUTPATIENT CLINIC VISITS IN THE FIRST 16 MONTHS OF THE COVID-19 PANDEMIC: SINGLE-CENTRE EXPERIENCE

Yazarlar: Hüseyin Kaplan | Gizem Cengiz | Senem Şaş | Emre Şenköy

Yayıncı: Erciyes University

Ana Başlıklar: İç Hastalıkları

Dergi: Sağlık Bilimleri Dergisi Vol.32 Issue 1, pp.106-112

Belge Tipi: Makale

Yayın Tarihi: 3/2023

Belge Dili: İngilizce

Document ID (Org No.): 2001286286

pISSN: 1018-3655

COVID-19

outpatient clinic

rheumatology

COVID-19

poliklinik

romatoloji

Sayı

Yazarlar:

Hüseyin Kaplan | Gizem Cengiz | Senem Şaş | Emre Şenköy

Yayıncı:

Erciyes University

Ana Başlıklar:

İç Hastalıkları

Dergi:

Sağlık Bilimleri Dergisi Vol.32 Issue 1, pp.106-112

Belge Tipi:

Makale

Yayın Tarihi:

3/2023

Belge Dili:

İngilizce

Document ID (Org No.):

2001286286

pISSN:

1018-3655